Clinical Trial: Breast Cancer Tumor Care Observational Programme
Study Status: Completed
Recruit Status: Completed
Study Type: Observational
Official Title: Breast Cancer Tumor Care Patient Observation Programme
Brief Summary: The purpose of this study is to investigate efficacy and tolerability under anastrozole (Arimidex) treatment.
Detailed Summary:
Sponsor: AstraZeneca
Current Primary Outcome: Progression of disease and tolerability in general [ Time Frame: Baseline, every 3 month ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Patient questionnaire to collect data on Incidence, time of onset and treatment of arthralgia [ Time Frame: Baseline, every 3 month ]
Original Secondary Outcome: Same as current
Information By: AstraZeneca
Dates:
Date Received: April 15, 2008
Date Started: February 2008
Date Completion:
Last Updated: June 5, 2012
Last Verified: June 2012